It specializes in developing innovative cell therapies, with a primary focus on addressing neonatal brain injuries caused by hypoxic-ischemic encephalopathy (HIE). This condition, resulting from oxygen deprivation during or shortly after birth, is a leading cause of neonatal deaths and long-term neurological impairments, such as cerebral palsy and